
We are delighted to announce two powerful additions to the Phenotypeca Advisory Board. Patrick Florent, an executive with a broad and diverse experience in Industrial Operation, Enterprise Integration and Global Alliances at GSK Vaccines, provides outstanding strategic direction for one of our key market areas. Anton Hutter, a European & UK patent attorney and partner in Venner Shipley’s Chemical & Life Sciences team, provides Intellectual Property expertise across all of our market areas. He has expertise in biotechnology and pharmaceuticals; in particular, he has a deep understanding of yeast molecular biology, biochemistry & genetics, including therapeutic antibodies and diagnostics, peptides and vaccines.